Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Baxter
Mallinckrodt
AstraZeneca
Dow

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Betaxolol hydrochloride; chlorthalidone - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for betaxolol hydrochloride; chlorthalidone and what is the scope of freedom to operate?

Betaxolol hydrochloride; chlorthalidone is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for betaxolol hydrochloride; chlorthalidone.

Summary for betaxolol hydrochloride; chlorthalidone
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 11
DailyMed Link:betaxolol hydrochloride; chlorthalidone at DailyMed

US Patents and Regulatory Information for betaxolol hydrochloride; chlorthalidone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-002 Oct 30, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-001 Oct 30, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for betaxolol hydrochloride; chlorthalidone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-001 Oct 30, 1992   Start Trial   Start Trial
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-001 Oct 30, 1992   Start Trial   Start Trial
Sanofi Aventis Us KERLEDEX betaxolol hydrochloride; chlorthalidone TABLET;ORAL 019807-002 Oct 30, 1992   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
AstraZeneca
Harvard Business School
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.